CD8A and neoplasm: These data demonstrate the extreme sensitivity of the TCR to minor conformational changes in the peptide, extend our understanding of CD8+ T-cell recognition of a prominent tumor target and have important implications for the design of altered peptide ligands for use in cancer vaccination.